Auscann Group (ASX: AC8) is a medicinal cannabis business. Auscann is spending money to expand the production of cannabis as countries around the world begin to embrace the use of cannabis in medicine. Canada became the second country to legalise recreational cannabis.
Australia’s share market, or the All Ordinaries Index (INDEXASX: XAO)(ASX: XAO), is up by 0.66% at lunch.
Futures contracts for the S&P/ASX 200 (INDEXASX:XJO)(ASX:XJO) index are pointing to a positive open on Thursday morning with Inghams Group Limited (ASX:ING) and Godfrey’s Group Limited (ASX:GFY) in focus.
Australia’s All Ordinaries (INDEXASX:XAO)(ASX:XAO) closed firmly lower on Wednesday.
The Australian share market, including the S&P/ASX 200 (INDEXASX:XJO)(ASX:XJO) and All Ordinaries (INDEXASX:XAO)(ASX:XAO), closed slightly higher on Thursday.
Shares of Cann Group Limited (ASX:CAN), Auscann Group Holdings Ltd (ASX:AC8), Creso Pharma Ltd (ASX:CPH), Stemcell United Ltd (ASX:SCU) and MMJ Phytotech Ltd (ASX:MMJ) have bounced on the Australian Government’s export approval.
